Results 21 to 30 of about 273,177 (229)

Rifampicin resistance in new bacteriologically confirmed pulmonary tuberculosis patients in Cameroon: a cross-sectional survey

BMC Research Notes, 2018
Objective In Cameroon, tuberculosis (TB) cases are diagnosed and treated within a nationwide network of 248 diagnostic and treatment centres. In 2016, the centers notified a total of 175 multidrug-resistant (MDR-)TB cases, most of them retreatment cases.
J. Noeske, A. Nana Yakam, J. L. Abena Foe, D. Nguafack, C. Kuaban   +4 more
doaj   +1 more source

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. [PDF]

, 2012
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB).
Varghese, B, Tony Reid, Paryani Roma, Mansoor Homa, Isaakidis, P, Paryani, Roma, Isaakidis, Petros, Cox, Helen S., Udwadia, Zarir, Sotgiu, Giovanni, Khan Samsuddin, Ladomirska, J, Cox, H S, Reid, Tony, Giovanni Battista Migliori, Ladomirska Joanna, Paryani, R, Da Silva Esdras, Udwadia Zarir, Petros Isaakidis, Peter Saranchuk, Joanna Ladomirska, Zarir Udwadia, Bhanumati Varghese, Roma Paryani, Ladomirska, Joanna, Varghese, Bhanumati, Sotgiu Giovanni, Khan, S, Migliori, Giovanni Battista, Isaakidis Petros, Saranchuk, Peter, Da Silva, Esdras, Mansoor, H, Homa Mansoor, Khan, Samsuddin, Saranchuk Peter, Esdras Da Silva, Migliori, G B, Migliori Giovanni Battista, Mansoor, Homa, Reid Tony, Varghese Bhanumati, Cox Helen S., Giovanni Sotgiu, Saranchuk, P, Da Silva, E, Udwadia, Z, Reid, T, Helen S Cox, Sotgiu, G, Samsuddin Khan   +51 more
core   +1 more source

82125 Multiple epidemics of multidrug-resistant tuberculosis revealed by spatial disease mapping and whole-genome sequencing analysis in urban China

Journal of Clinical and Translational Science, 2021
IMPACT: Our study will integrate state-of-the-art methods in pathogen genomics, epidemiology, and geospatial analysis to identify both host- and pathogen-factors driving the MDR-TB transmission and the study outcome can inform the design of targeted ...
Chongguang Yang, Yangyi Zhang, Yuan Jiang, Zheyuan Wu, Xin Shen, Joshua L. Warren, Ted Cohen   +6 more
doaj   +1 more source

Comparison of Line Probe Assay (LPA) and Mycobacterium Growth Indicator Tubes (MGIT) Assay for Second-line TB Drug Susceptibility Testing [PDF]

, 2021
BACKGROUND: Tuberculosis (TB) infection is one of the most prominent health issues in the world, including in Indonesia. TB is evolving into multidrug-resistant tuberculosis (MDR-TB) and requiring second-line TB drugs. Mycobacterium growth indicator tube
Choerunisa, Towifah Fauziah, Rostini, Tiene, Lismayanti, Leni, Bayusantika, Ryan, Parwati, Ida   +4 more
core   +1 more source

TB and MDR-TB: what is new in 2012? [PDF]

Breathe, 2012
Educational aimsTo understand the need for new diagnostics for tuberculosis (TB) and describe the role of GeneXpertTo describe to what extent drug resistance affects clinical management of multi/extensively drug resistant-TB, and the importance of having new drugs to manage these difficult-to-treat casesTo describe the current evidence on TB/HIV ...
Tadolini, Marina, Centis, Rosella, D'Ambrosio, Lia, Battista Migliori, Giovanni   +3 more
openaire   +1 more source

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

Infectious Diseases of Poverty, 2020
Background China incurs an extremely low treatment coverage of multidrug-resistant tuberculosis (MDR-TB). This study aimed to understand the experience of MDR-TB patients on quality of health care, and the clinical impact through an up to six-year follow-
Xu-Bin Zheng, Vinod K. Diwan, Qi Zhao, Yi Hu, Judith Bruchfeld, Wei-Li Jiang, Sven Hoffner, Biao Xu   +7 more
doaj   +1 more source

Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres

BMC Infectious Diseases, 2019
Background The increased incidence of drug-resistant TB is a major challenge for effective TB control. Limited therapeutic options and poor treatment outcomes of DR-TB may increase drug-resistance rates.
Niccolò Riccardi, Riccardo Alagna, Laura Saderi, Maurizio Ferrarese, Paola Castellotti, Ester Mazzola, Saverio De Lorenzo, Pietro Viggiani, Zarir Udwadia, Giorgio Besozzi, Daniela Cirillo, Giovanni Sotgiu, Luigi Codecasa, for StopTB Italia Onlus Group   +13 more
doaj   +1 more source

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013

Chinese Medical Journal, 2017
Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious TB subpopulations excluding the new TB patients. This study aimed to examine MDR-TB burden among the new TB patients.
Ying Peng, Song-Hua Chen, Le Zhang, Bin Chen, Ming-Wu Zhang, Tie-Niu He, Fei Wang, Cheng-Liang Chai, Lin Zhou, Yu Zhang, Xiao-Meng Wang, Zhongwei Jia   +11 more
doaj   +1 more source

Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling

Infectious Diseases of Poverty, 2020
Background Multidrug-resistant tuberculosis (MDR-TB) is on the rise in China. This study used a dynamic Markov model to predict the longitudinal trends of MDR-TB in China by 2050 and to assess the effects of alternative control measures.
Bing-Ying Li, Wen-Pei Shi, Chang-Ming Zhou, Qi Zhao, Vinod K Diwan, Xu-Bin Zheng, Yang Li, Sven Hoffner, Biao Xu   +8 more
doaj   +1 more source

Screening and identification of differentially expressed long non-coding RNAs in multidrug-resistant tuberculosis [PDF]

PeerJ, 2022
Background Efforts to eradicate tuberculosis are largely threatened by drug-resistant tuberculosis, particularly, multidrug-resistant tuberculosis (MDR-TB).
Junwei Zhao, ShuHui Gao, Chunguang Chen, Hui Li, Shaohua Wang, Yongmin Yu, Liang Ming   +6 more
doaj   +2 more sources